The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Iizumi, Yosuke ^a   Oishi, Masakatsu ^a   Taniguchi, Tomoyuki ^a   Goi, Wakana ^a   Sowa, Yoshihiro ^a   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CYCLIN DEPENDENT KINASE 1; MAGNETIC FG BEAD; NANOBEAD; RIBOSOME PROTEIN; RIBOSOME PROTEIN S9; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; COLON CANCER; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; UPREGULATION;

APIGENIN; CDC2 PROTEIN KINASE; CELL LINE, TUMOR; DOWN-REGULATION; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RIBOSOMAL PROTEINS;

EID: 84883242585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073219     Document Type: Article

References (41)

1. Nishizuka Y, (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698. doi:10.1038/308693a0. PubMed: 6232463.
2. Nishino H, Nagao M, Fujiki H, Sugimura T, (1983) Role of flavonoids in suppressing the enhancement of phospholipid metabolism by tumor promoters. Cancer Lett 21: 1-8. doi:10.1016/0304-3835(83)90075-7. PubMed: 6640509.
3. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, et al. (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13. doi:10.1016/0014-5793(90)80053-L. PubMed: 2298289.
4. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, et al. (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331. PubMed: 8443813.
5. Sato F, Matsukawa Y, Matsumoto K, Nishino H, Sakai T, (1994) Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells. Biochem Biophys Res Commun 204: 578-584. doi:10.1006/bbrc.1994.2498. PubMed: 7980517.
6. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y, et al. (1998) Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett 437: 61-64. doi:10.1016/S0014-5793(98)01198-3. PubMed: 9804172.
7. Zi X, Agarwal R, (1999) Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci U S A 96: 7490-7495. doi:10.1073/pnas.96.13.7490. PubMed: 10377442.
8. Hsu SL, Hsieh YC, Hsieh WC, Chou CJ, (2001) Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules. Eur J Pharmacol 425: 165-171. doi:10.1016/S0014-2999(01)01144-X. PubMed: 11513834.
9. Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R, (2006) Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene 25: 1053-1069. doi:10.1038/sj.onc.1209146. PubMed: 16205633.
10. Khan N, Afaq F, Syed DN, Mukhtar H, (2008) Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 29: 1049-1056. doi:10.1093/carcin/bgn078. PubMed: 18359761.
11. Kim DI, Lee SJ, Lee SB, Park K, Kim WJ, et al. (2008) Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis 29: 1701-1709. doi:10.1093/carcin/bgn055. PubMed: 18296682.
12. Ong CS, Zhou J, Ong CN, Shen HM, (2010) Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Cancer Lett 298: 167-175. doi:10.1016/j.canlet.2010.07.001. PubMed: 20655656.
13. Warner JR, McIntosh KB, (2009) How common are extraribosomal functions of ribosomal proteins? Mol Cell 34: 3-11. doi:10.1016/j.molcel.2009.03.006. PubMed: 19362532.
14. Zhang Y, Lu H, (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell 16: 369-377. doi:10.1016/j.ccr.2009.09.024. PubMed: 19878869.
15. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH, (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587. doi:10.1016/S1535-6108(03)00134-X. PubMed: 12842086.
16. Dai MS, Lu H, (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 279: 44475-44482. doi:10.1074/jbc.M403722200. PubMed: 15308643.
17. Dai MS, Zeng SX, Jin Y, Sun XX, David L, et al. (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654-7668. doi:10.1128/MCB.24.17.7654-7668.2004. PubMed: 15314173.
18. Wan F, Anderson DE, Barnitz RA, Snow A, Bidere N, et al. (2007) Ribosomal protein S3: a KH domain subunit in NF-κB complexes that mediates selective gene regulation. Cell 131: 927-939. doi:10.1016/j.cell.2007.10.009. PubMed: 18045535.
19. Gao X, Wan F, Mateo K, Callegari E, Wang D, et al. (2009) Bacterial effector binding to ribosomal protein S3 subverts NF-κB function. PLOS Pathog 5: e1000708.
20. Wan F, Weaver A, Gao X, Bern M, Hardwidge PR, et al. (2011) IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7. Nat Immunol pp. 12: 335-343.
21. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD, (1996) Flavonoids activate wild-type p53. Oncogene 13: 1605-1614. PubMed: 8895505.
22. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, et al. (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20: 1945-1952. doi:10.1093/carcin/20.10.1945. PubMed: 10506109.
23. Shimizu N, Sugimoto K, Tang J, Nishi T, Sato I, et al. (2000) High-performance affinity beads for identifying drug receptors. Nat Biotechnol 18: 877-881. doi:10.1038/78496. PubMed: 10932159.
24. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, et al. (2010) Identification of a primary target of thalidomide teratogenicity. Science 327: 1345-1350. doi:10.1126/science.1177319. PubMed: 20223979.
25. Wei H, Tye L, Bresnick E, Birt DF, (1990) Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50: 499-502. PubMed: 2105157.
26. Birt DF, Mitchell D, Gold B, Pour P, Pinch HC, (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17: 85-91. PubMed: 9066634.
27. Zhong Y, Krisanapun C, Lee SH, Nualsanit T, Sams C, et al. (2010) Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53. Eur J Cancer 46: 3365-3374. doi:10.1016/j.ejca.2010.07.007. PubMed: 20709524.
28. Lepley DM, Li B, Birt DF, Pelling JC, (1996) The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375. doi:10.1093/carcin/17.11.2367. PubMed: 8968050.
29. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, et al. (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28: 102-110. doi:10.1002/1098-2744(200006)28:2. PubMed: 10900467.
30. Ujiki MB, Ding XZ, Salabat MR, Bentrem DJ, Golkar L, et al. (2006) Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 5: 76. doi:10.1186/1476-4598-5-76. PubMed: 17196098.
31. Lepley DM, Pelling JC, (1997) Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82. doi:10.1002/(SICI)1098-2744(199707)19:2. PubMed: 9210954.
32. Takagaki N, Sowa Y, Oki T, Nakanishi R, Yogosawa S, et al. (2005) Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol 26: 185-189. PubMed: 15586239.
33. Lindström MS, Zhang Y, (2008) Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation. J Biol Chem 283: 15568-15576. doi:10.1074/jbc.M801151200. PubMed: 18420587.
34. Lindström MS, Nistér M, (2010) Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLOS ONE 5: e9578. doi:10.1371/journal.pone.0009578. PubMed: 20221446.
35. Bai C, Richman R, Elledge SJ, (1994) Human cyclin F. EMBO J 13: 6087-6098. PubMed: 7813445.
36. Tsaytler P, Harding HP, Ron D, Bertolotti A, (2011) Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332: 91-94. doi:10.1126/science.1201396. PubMed: 21385720.
37. Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, et al. (2011) Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 4: 1366-1377. doi:10.1158/1940-6207.CAPR-11-0301. PubMed: 21750208.
38. McVean M, Xiao H, Isobe K, Pelling JC, (2000) Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 21: 633-639. doi:10.1093/carcin/21.4.633. PubMed: 10753197.
39. Torkin R, Lavoie JF, Kaplan DR, Yeger H, (2005) Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma. Mol Cancer Ther 4: 1-11. doi:10.1186/1476-4598-4-1. PubMed: 15657348.
40. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, et al. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425. PubMed: 11566638.
41. Arango D, Morohashi K, Yilmaz A, Kuramochi K, Parihar A, et al. (2013) Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci U S A 110: E2153-E2162. doi:10.1073/pnas.1303726110. PubMed: 23697369.